首页/数据集/Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer

Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer

ChEBI2014-03-31 更新2026-07-21 收录

前列腺癌靶向治疗

BET蛋白抑制剂

数据链接：

https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-GEOD-56352 数据链接链接失效反馈

官方服务：

资源简介：

Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer

应用场景：

创建时间：

2014-03-31

前列腺癌靶向治疗

DYRK2

Prostate cancer (PCa) is a common male cancer with high incidence and mortality, and hormonal therapy as the major treatment for PCa patients is troubled by the inevitable resistance that makes us ide

NIAID Data Ecosystem100

前列腺癌靶向治疗

雄激素受体拮抗剂机制

The androgen receptor (AR) surface-directed antagonist MJC13 inhibits AR function and proliferation of prostate cancer (PC) cells. These effects are related to arrest of an AR/chaperone complex in the

Figshare2016-01-15 更新50

Supplementary Table from Blocking PI3K p110β Attenuates Development of PTEN-Deficient Castration-Resistant Prostate Cancer

前列腺癌靶向治疗

PI3K信号通路

Supplementary Table from Blocking PI3K p110β Attenuates Development of PTEN-Deficient Castration-Resistant Prostate Cancer

Figshare2022-05-04 更新40

Physachenolide C is a Potent, Selective BET Inhibitor

BET抑制剂

前列腺癌靶向治疗

A pulldown using a biotinylated natural product of interest in the 17β-hydroxywithanolide (17-BHW) class, physachenolide C (PCC), identified the bromodomain and extra-terminal domain (BET) family of p

Figshare2022-12-28 更新80

Treatment with the WNT5A-mimicking Peptide Foxy-5 Effectively Reduces the Metastatic Spread of WNT5A-low Prostate Cancer Cells in an Orthotopic Mouse Model

前列腺癌靶向治疗

癌症转移抑制模型

The raw data behind the figures of the published paper

Figshare2017-08-28 更新40